Journal of Cardiac Failure
Volume 16, Issue 2 , Pages 135-141.e2 , February 2010

The Impact of Perceived Adverse Effects on Medication Changes in Heart Failure Patients

  • Ruth H.E. De Smedt, MSc

      Affiliations

    • Department of Clinical Pharmacology, University of Groningen, the Netherlands
    • Corresponding Author InformationReprint requests: RHE De Smedt, University Medical Center Groningen, Sector F, Clinical Pharmacology, FB 20, 9713 AW Groningen, the Netherlands; Tel: +31 50 3632820; Fax: +31 50 3632812.
    • ,
  • Tiny Jaarsma, PhD

      Affiliations

    • Department of Cardiology, University of Groningen, the Netherlands
    • ,
  • Flora M. Haaijer-Ruskamp, PhD

      Affiliations

    • Department of Clinical Pharmacology, University of Groningen, the Netherlands
    • Graduate School for Health Research Share, University of Groningen, the Netherlands
    • ,
  • Petra Denig, PhD

      Affiliations

    • Department of Clinical Pharmacology, University of Groningen, the Netherlands
    • Graduate School for Health Research Share, University of Groningen, the Netherlands

Received 20 May 2009 ,Revised 23 September 2009 ,Accepted 24 September 2009.

References 

  1. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail. 2008;10:933–989
  2. Heart Failure Society Of America. Executive summary: HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail. 2006;12:10–38
  3. De Smedt RH, Denig P, Haaijer-Ruskamp FM, Jaarsma T. Perceived medication adverse effects and coping strategies reported by chronic heart failure patients. Int J Clin Pract. 2009;63:233–242
  4. Richard C, Lussier MT. Measuring patient and physician participation in exchanges on medications: dialogue ratio, preponderance of initiative, and dialogical roles. Patient Educ Couns. 2007;65:329–341
  5. Gandhi TK, Burstin HR, Cook EF, Puopolo AL, Haas JS, Brennan TA, et al. Drug complications in outpatients. J Gen Intern Med. 2000;15:149–154
  6. van der Wal MH, Jaarsma T, van Veldhuisen DJ. Non-compliance in patients with heart failure; how can we manage it?. Eur J Heart Fail. 2005;7:5–17
  7. van der Wal MH, Jaarsma T. Adherence in heart failure in the elderly: problem and possible solutions. Int J Cardiol. 2008;125:203–208
  8. Gandhi TK, Weingart SN, Borus J, Seger AC, Peterson J, Burdick E, et al. Adverse drug events in ambulatory care. N Engl J Med. 2003;348:1556–1564
  9. Forster AJ, Murff HJ, Peterson JF, Gandhi TK, Bates DW. Adverse drug events occurring following hospital discharge. J Gen Intern Med. 2005;20:317–323
  10. Jaarsma T, van der Wal MH, Hogenhuis J, Lesman I, Luttik ML, Veeger NJ, et al. Design and methodology of the COACH study: a multicenter randomised Coordinating study evaluating Outcomes of Advising and Counselling in Heart failure. Eur J Heart Fail. 2004;6:227–233
  11. Jaarsma T, van der Wal MH, Lesman-Leegte I, Luttik ML, Hogenhuis J, Veeger NJ, et al. Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH). Arch Intern Med. 2008;168:316–324
  12. College voor zorgverzekeringen. Farmacotherapeutisch Kompas 2007. Utrecht (NL). 2007.
  13. Altman DG, Bland JM. Interaction revisited: the difference between two estimates. BMJ. 2009;326:219
  14. Bekelman DB, Havranek EP, Becker DM, Kutner JS, Peterson PN, Wittstein IS, et al. Symptoms, depression, and quality of life in patients with heart failure. J Card Fail. 2007;13:643–648
  15. Zambroski CH, Moser DK, Bhat G, Ziegler C. Impact of symptom prevalence and symptom burden on quality of life in patients with heart failure. Eur J Cardiovasc Nurs. 2005;4:198–206
  16. Weingart SN, Gandhi TK, Seger AC, Seger DL, Borus J, Burdick E, et al. Patient-reported medication symptoms in primary care. Arch Intern Med. 2005;165:234–240
  17. Jarernsiripornkul N, Krska J, Capps PA, Richards RM, Lee A. Patient reporting of potential adverse drug reactions: a methodological study. Br J Clin Pharmacol. 2002;53:318–325
  18. Davis RE, Koutantji M, Vincent CA. How willing are patients to question healthcare staff on issues related to the quality and safety of their healthcare? An exploratory study. Qual Saf Health Care. 2008;17:90–96
  19. Laurant MGH, Hermens RPMG, Braspenning JCC, Akkermans RP, Sibbald B, Grol RPTM. An overview of patients' preference for, and satisfaction with, care provided by general practitioners and nurse practitioners. J Clin Nurs. 2008;17:2690–2698
  20. Lampela P, Hartikainen S, Sulkava R, Huupponen R. Adverse drug effects in elderly people—a disparity between clinical examination and adverse effects self-reported by the patient. Eur J Clin Pharmacol. 2007;63:509–515
  21. Jarernsiripornkul N, Kakaew W, Loalukkana W, Krska J. Adverse drug reaction monitoring: comparing doctor and patient reporting for new drugs. Pharmacoepidemiol Drug Saf. 2009;18:240–245
  22. Cosentino M, Leoni O, Oria C, Michielotto D, Massimo E, Lecchini S, et al. Hospital-based survey of doctors' attitudes to adverse drug reactions and perception of drug-related risk for adverse reaction occurrence. Pharmacoepidemiol Drug Saf. 1999;8:S27–S35
  23. Golomb BA, McGraw JJ, Evans MA, Dimsdale JE. Physician response to patient reports of adverse drug effects: implications for patient-targeted adverse effect surveillance. Drug Saf. 2007;30:669–675
  24. Rogers A, Addington-Hall JM, McCoy AS, Edmonds PM, Abery AJ, Coats AJ, et al. A qualitative study of chronic heart failure patients' understanding of their symptoms and drug therapy. Eur J Heart Fail. 2002;4:283–287
  25. Stevenson FA, Barry CA, Britten N, Barber N, Bradley CP. Doctor-patient communication about drugs: the evidence for shared decision making. Soc Sci Med. 2000;50:829–840
  26. Dusing R, Weisser B, Mengden T, Vetter H. Changes in antihypertensive therapy—the role of adverse effects and compliance. Blood Press. 1998;7:313–315
  27. Ziegler DK, Mosier MC, Buenaver M, Okuyemi K. How much information about adverse effects of medication do patients want from physicians?. Arch Intern Med. 2001;161:706–713
  28. Tangiisuran B, Wright J, Van der CT, Rajkumar C. Adverse drug reactions in elderly: challenges in identification and improving preventative strategies. Age Ageing. 2009;38:358–359

 The COACH study was supported by grant 2000Z003 from the Netherlands Heart Foundation. This study was financed through an Ebbo Emmius scholarship at the University of Groningen, the Netherlands.

PII: S1071-9164(09)01090-2

doi: 10.1016/j.cardfail.2009.09.006

Journal of Cardiac Failure
Volume 16, Issue 2 , Pages 135-141.e2 , February 2010

Article Tools

* Image Usage & Resolution